Advertisement

Topics

Wider Than AZ’s PACIFIC – Novartis Has Broad NSCLC Plans For Canakinumab

08:27 EST 15 Nov 2017 | SCRIP

Novartis is taking its unexpected CANTOS cancer findings for canakinumab and running with them to Phase III in an adjuvant...

      

Related Stories

 

Original Article: Wider Than AZ’s PACIFIC – Novartis Has Broad NSCLC Plans For Canakinumab

NEXT ARTICLE

More From BioPortfolio on "Wider Than AZ’s PACIFIC – Novartis Has Broad NSCLC Plans For Canakinumab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...